Aonjittra Phanrungsuwan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Aonjittra Phanrungsuwan has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Brian Lee Foster
Division of Biosciences, College of Dentistry, The Ohio State University, Columbus, OH 43210, USA
9 shared publications - José Luis Millán
Sanford Children's Health Research Center, Sanford Burnham Prebys Medical Discovery Institute , La Jolla, CA 92037
4 shared publications Bella Donnelly
Division of Biosciences , College of Dentistry, The Ohio State University, Columbus, OH 43210
3 shared publications- Flavia Amadeu de Oliveira
Sanford Children's Health Research Center, Sanford Burnham Prebys Medical Discovery Institute , La Jolla, CA 92037
3 shared publications - Anibal Diogenes
Department of Endodontics, University of Texas Health Science Center at San Antonio, San Antonio, Texas
2 shared publications - Eva S. Liu
Division of Endocrinology, Diabetes, and Hypertension, Brigham and Women's Hospital, Harvard Medical School , Boston, MA 02115
2 shared publications
Latest Publications
- Open Access
- 16 September 2026
- Published by Elsevier in SSRN Electronic Journal
A Quantitative X-Ray Microcomputed Tomography Workflow for Dentoalveolar Tissue Analysis of Soft and Hard Tissues in the Mouse Hemimandible
Dentoalveolar tissues in the maxilla and mandible combine mineralized and nonmineralized components optimized for mastication. Such a combination of hard and soft tissues is difficult to simultaneously visualize and quantify by X-ray microcomputed tomography (µCT). While µCT provides excellent high-resolution, nondestructive imaging of mineralized structures, soft tissues such as predentin, pulp, and periodontal ligament provide only low X-ray attenuation (low contrast) and are often regretfully excluded from analyses. In addition, the relatively high water content of soft tissues further reduces image contrast. Whereas some contrast-enhancing approaches have been used for soft tissues, these may alter mineralized tissues. Here, we present a reproducible µCT-based workflow integrating iodine stain contrast enhancement combined with dehydration by critical-point drying, and hybrid segmentation for 3D multiscale analysis of mouse hemimandibles. Segmentation is then combined with intensity-based analysis methods using deep learning-assisted refinement (U-Net). The workflow facilitates simultaneous visualization and quantification of both mineralized and soft tissues, including enamel, dentin, predentin, pulp, cementum, mandibular and alveolar bone, and periodontal ligament. Quantitative outputs include volumetric measurements, thickness mapping, and normalized tissue fractions, among other metrics. The workflow applied to the Hyp mouse model of X-linked hypophosphatemia effectively detected established alterations in pulp morphology in pathologic mineralized tissues. This imaging and quantitative workflow establishes a reproducible and scalable framework for simultaneous multi-tissue dentoalveolar analysis, which can particularly enable quantitative comparisons between physiologic and pathologic spontaneous and transgenic mouse models of disease.
- 16 September 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessA Quantitative X-Ray Microcomputed Tomography Workflow for Dentoalveolar Tissue Analysis of Soft and Hard Tissues in the Mouse Hemimandible
Dentoalveolar tissues in the maxilla and mandible combine mineralized and nonmineralized components optimized for mastication. Such a combination of hard and soft tissues is difficult to simultaneously visualize and quantify by X-ray microcomputed tomography (µCT). While µCT provides excellent high-resolution, nondestructive imaging of mineralized structures, soft tissues such as predentin, pulp, and periodontal ligament provide only low X-ray attenuation (low contrast) and are often regretfully excluded from analyses. In addition, the relatively high water content of soft tissues further reduces image contrast. Whereas some contrast-enhancing approaches have been used for soft tissues, these may alter mineralized tissues. Here, we present a reproducible µCT-based workflow integrating iodine stain contrast enhancement combined with dehydration by critical-point drying, and hybrid segmentation for 3D multiscale analysis of mouse hemimandibles. Segmentation is then combined with intensity-based analysis methods using deep learning-assisted refinement (U-Net). The workflow facilitates simultaneous visualization and quantification of both mineralized and soft tissues, including enamel, dentin, predentin, pulp, cementum, mandibular and alveolar bone, and periodontal ligament. Quantitative outputs include volumetric measurements, thickness mapping, and normalized tissue fractions, among other metrics. The workflow applied to the Hyp mouse model of X-linked hypophosphatemia effectively detected established alterations in pulp morphology in pathologic mineralized tissues. This imaging and quantitative workflow establishes a reproducible and scalable framework for simultaneous multi-tissue dentoalveolar analysis, which can particularly enable quantitative comparisons between physiologic and pathologic spontaneous and transgenic mouse models of disease.
- Open Access
- 26 January 2026
- Published by Wiley in Journal of Periodontology
- Vol. 97 (5) , 1071-1085
Mineral‐targeted alkaline phosphatase improves bone graft‐mediated alveolar bone defect healing in mice
Background: Alveolar bone loss challenges tooth retention and implant placement. Freeze‐dried bone allograft (FDBA) is widely used for alveolar ridge preservation but has limitations in resorption rate and healing time. In this proof‐of‐concept study, we tested whether pro‐mineralization enzyme, tissue‐nonspecific alkaline phosphatase (TNAP) enhances bone healing. Methods: Seven‐week‐old mice ( n = 4‐6/group; equal numbers of males and females) underwent maxillary molar extraction and standardized alveolar defect creation. Mice were assigned to sham, FDBA with saline (BGS) or FDBA with mineral‐targeted TNAP‐Fc‐D 10 (BGT). Healing was assessed using microcomputed tomography (micro‐CT), serum alkaline phosphatase (ALP) levels, histology, and immunohistochemistry, between 14‐ and 60‐days post‐procedure (dpp). Intergroup comparisons were analyzed by one‐way ANOVA and post‐hoc Tukey test ( α = 0.05) Results: At 14 dpp, the BGT group demonstrated significantly greater bone volume fraction (BV/TV) and bone mineral density (BMD) compared with BGS ( p < 0.01, p < 0.05) and sham groups ( p < 0.001). Alveolar bone volume was greater than sham ( p < 0.001). Alveolar bone dimension (height and width) was significantly more stable in the BGT group ( p < 0.05). Although BV/TV at 60 dpp showed no significant differences, BGT maintained higher BMD and alveolar bone width stability ( p < 0.01). Histological and immunohistochemical analyses revealed increased new bone formation and greater bone marker expression in the short‐term BGT group ( p < 0.05). No changes in serum ALP levels were detected. Conclusions: TNAP‐Fc‐D 10 with FDBA significantly enhances early alveolar bone healing and dimensional stability. While long‐term volumetric gains were not observed, sustained improvements in mineral density and ridge preservation support TNAP as a promising biologic for alveolar ridge preservation. Plain language summary: When people lose teeth, keeping enough bone in the jaw is critical for future treatments like dental implants. A common material used to rebuild bone is called freeze‐dried bone allograft (FDBA), but it does not always heal quickly or completely. In this study, we tested whether adding a special enzyme called TNAP, which helps build bones naturally, could make FDBA work better. After extracting teeth and creating bone defects in mice, we compared healing between three groups: control (sham), FDBA + saline, and FDBA + engineered TNAP‐Fc‐D 10 . After 2 weeks, the group that received FDBA+TNAP‐Fc‐D 10 showed more new bone formation and better preservation of the size of the jawbone. Even after 2 months, their bone remained denser and more stable compared with the other groups. Importantly, we found no signs of unwanted side effects in the blood. These results suggest that adding TNAP‐Fc‐D 10 could make bone grafts more effective early on, helping preserve jaw structure better over time. More research is needed to fine‐tune the treatment and see how well it works in humans.
- 26 January 2026
- Published by Wiley in Journal of Periodontology
- Vol. 97 (5) , 1071-1085
Open AccessMineral‐targeted alkaline phosphatase improves bone graft‐mediated alveolar bone defect healing in mice
Background: Alveolar bone loss challenges tooth retention and implant placement. Freeze‐dried bone allograft (FDBA) is widely used for alveolar ridge preservation but has limitations in resorption rate and healing time. In this proof‐of‐concept study, we tested whether pro‐mineralization enzyme, tissue‐nonspecific alkaline phosphatase (TNAP) enhances bone healing. Methods: Seven‐week‐old mice ( n = 4‐6/group; equal numbers of males and females) underwent maxillary molar extraction and standardized alveolar defect creation. Mice were assigned to sham, FDBA with saline (BGS) or FDBA with mineral‐targeted TNAP‐Fc‐D 10 (BGT). Healing was assessed using microcomputed tomography (micro‐CT), serum alkaline phosphatase (ALP) levels, histology, and immunohistochemistry, between 14‐ and 60‐days post‐procedure (dpp). Intergroup comparisons were analyzed by one‐way ANOVA and post‐hoc Tukey test ( α = 0.05) Results: At 14 dpp, the BGT group demonstrated significantly greater bone volume fraction (BV/TV) and bone mineral density (BMD) compared with BGS ( p < 0.01, p < 0.05) and sham groups ( p < 0.001). Alveolar bone volume was greater than sham ( p < 0.001). Alveolar bone dimension (height and width) was significantly more stable in the BGT group ( p < 0.05). Although BV/TV at 60 dpp showed no significant differences, BGT maintained higher BMD and alveolar bone width stability ( p < 0.01). Histological and immunohistochemical analyses revealed increased new bone formation and greater bone marker expression in the short‐term BGT group ( p < 0.05). No changes in serum ALP levels were detected. Conclusions: TNAP‐Fc‐D 10 with FDBA significantly enhances early alveolar bone healing and dimensional stability. While long‐term volumetric gains were not observed, sustained improvements in mineral density and ridge preservation support TNAP as a promising biologic for alveolar ridge preservation. Plain language summary: When people lose teeth, keeping enough bone in the jaw is critical for future treatments like dental implants. A common material used to rebuild bone is called freeze‐dried bone allograft (FDBA), but it does not always heal quickly or completely. In this study, we tested whether adding a special enzyme called TNAP, which helps build bones naturally, could make FDBA work better. After extracting teeth and creating bone defects in mice, we compared healing between three groups: control (sham), FDBA + saline, and FDBA + engineered TNAP‐Fc‐D 10 . After 2 weeks, the group that received FDBA+TNAP‐Fc‐D 10 showed more new bone formation and better preservation of the size of the jawbone. Even after 2 months, their bone remained denser and more stable compared with the other groups. Importantly, we found no signs of unwanted side effects in the blood. These results suggest that adding TNAP‐Fc‐D 10 could make bone grafts more effective early on, helping preserve jaw structure better over time. More research is needed to fine‐tune the treatment and see how well it works in humans.
- Open Access
- 28 October 2025
- Published by Oxford University Press (OUP) in JBMR Plus
- Vol. 9 (12)
Genetic reduction or deletion of osteopontin in osteomalacic Hyp mice fails to ameliorate dentoalveolar defects
X-linked hypophosphatemia (XLH) is caused by inactivating mutations in PHEX, leading to disturbed mineral metabolism, rickets, and osteomalacia. Dentoalveolar defects affecting dentin, cementum, and alveolar bone, contribute to dental abscesses and periodontal breakdown. Limited efficacy of current therapies for ameliorating XLH-associated dentoalveolar effects suggests mechanisms of disease that remain unchecked. Increased production and abnormal distribution of osteopontin (OPN) is thought to contribute to XLH-associated mineralization defects. Osteopontin is a secreted phosphoprotein and mineralization inhibitor, and a substrate of PHEX. To investigate the potential role of OPN in the pathology of XLH-associated dentoalveolar defects, a genetic approach was used to ablate or diminish Spp1/OPN in the Hyp mouse model of XLH. One or both Spp1 alleles in Hyp mice were deleted and tissues were analyzed at 60 d postnatally (dpn). Micro-CT showed no differences in volumes or densities of dentin and alveolar bone in Hyp mice lacking one or both Spp1 alleles, as compared to control Hyp mice. Histological assessment showed no improvements in cementum or periodontal ligament attachment, and dynamic mechanical analysis revealed no normalization of periodontal mechanical properties. While OPN may play a role in regulating dentoalveolar mineralization, diminishing OPN alone was not sufficient to substantially ameliorate XLH-associated defects.
- 28 October 2025
- Published by Oxford University Press (OUP) in JBMR Plus
- Vol. 9 (12)
Open AccessGenetic reduction or deletion of osteopontin in osteomalacic Hyp mice fails to ameliorate dentoalveolar defects
X-linked hypophosphatemia (XLH) is caused by inactivating mutations in PHEX, leading to disturbed mineral metabolism, rickets, and osteomalacia. Dentoalveolar defects affecting dentin, cementum, and alveolar bone, contribute to dental abscesses and periodontal breakdown. Limited efficacy of current therapies for ameliorating XLH-associated dentoalveolar effects suggests mechanisms of disease that remain unchecked. Increased production and abnormal distribution of osteopontin (OPN) is thought to contribute to XLH-associated mineralization defects. Osteopontin is a secreted phosphoprotein and mineralization inhibitor, and a substrate of PHEX. To investigate the potential role of OPN in the pathology of XLH-associated dentoalveolar defects, a genetic approach was used to ablate or diminish Spp1/OPN in the Hyp mouse model of XLH. One or both Spp1 alleles in Hyp mice were deleted and tissues were analyzed at 60 d postnatally (dpn). Micro-CT showed no differences in volumes or densities of dentin and alveolar bone in Hyp mice lacking one or both Spp1 alleles, as compared to control Hyp mice. Histological assessment showed no improvements in cementum or periodontal ligament attachment, and dynamic mechanical analysis revealed no normalization of periodontal mechanical properties. While OPN may play a role in regulating dentoalveolar mineralization, diminishing OPN alone was not sufficient to substantially ameliorate XLH-associated defects.
- Open Access
- 22 October 2025
- Published by Oxford University Press (OUP) in JBMR Plus
- Vol. 9 (12)
Proof-of-principle for enhanced dentoalveolar mineralization using exogenous tissue-nonspecific alkaline phosphatase in the Hyp mouse model of X-linked hypophosphatemia
X-linked hypophosphatemia (XLH) is caused by mutations in the PHEX gene, which leads to increased levels of fibroblast growth factor 23 and hypophosphatemia, contributing to rickets, osteomalacia, and dentoalveolar defects, including severe dentin hypomineralization, thin cementum, and alveolar bone osteomalacia. Current XLH treatment options appear to have limited efficacy on dentoalveolar tissues, suggesting underlying disease mechanisms that remain unchecked. Increased production of inorganic pyrophosphate (PPi) and osteopontin (OPN), both mineralization inhibitors, has been posited to contribute to mineralization defects in XLH. The enzyme, tissue-nonspecific alkaline phosphatase (TNAP) reduces PPi levels via hydrolysis and inactivates OPN by dephosphorylation. Our previous study showed improved alveolar bone socket healing in Hyp mice administered mineralized tissue-targeted TNAP (TNAP-Fc-D10). We hypothesized that increased TNAP would partially ameliorate developmental mineralization defects in XLH by dually reducing PPi levels and dephosphorylating and inactivating OPN. In a proof-of-principle study to investigate pathological mechanisms, we delivered systemic (subcutaneous injection) and local (submucosal injection to mandibles) TNAP-Fc-D10 injections to the Hyp mutant mouse model of XLH from 7 to 60 d postnatal (dpn). While systemic delivery was ineffective at improving dentin or bone properties, micro-CT and histology analyses demonstrated that local delivery of TNAP-Fc-D10 increased dentin thickness, root length, alveolar bone volume, alveolar bone proper (ABP) volume and density, PDL attachment, and acellular cementum thickness, compared to control Hyp mice receiving a sham injection. Dynamic mechanical testing confirmed partially improved mechanical properties in locally treated vs untreated Hyp mice, suggesting incompletely improved periodontal function. Quantitative PCR revealed increased Dspp expression in molars of treated Hyp mice. In conclusion, we found TNAP administration reduced dentoalveolar defects in Hyp mice when delivered locally into dentoalveolar structures, proof-of-principle pointing to a pathological contribution by PPi and/or OPN and highlighting a promising adjunctive approach considering limitations of current treatment modalities.
- 22 October 2025
- Published by Oxford University Press (OUP) in JBMR Plus
- Vol. 9 (12)
Open AccessProof-of-principle for enhanced dentoalveolar mineralization using exogenous tissue-nonspecific alkaline phosphatase in the Hyp mouse model of X-linked hypophosphatemia
X-linked hypophosphatemia (XLH) is caused by mutations in the PHEX gene, which leads to increased levels of fibroblast growth factor 23 and hypophosphatemia, contributing to rickets, osteomalacia, and dentoalveolar defects, including severe dentin hypomineralization, thin cementum, and alveolar bone osteomalacia. Current XLH treatment options appear to have limited efficacy on dentoalveolar tissues, suggesting underlying disease mechanisms that remain unchecked. Increased production of inorganic pyrophosphate (PPi) and osteopontin (OPN), both mineralization inhibitors, has been posited to contribute to mineralization defects in XLH. The enzyme, tissue-nonspecific alkaline phosphatase (TNAP) reduces PPi levels via hydrolysis and inactivates OPN by dephosphorylation. Our previous study showed improved alveolar bone socket healing in Hyp mice administered mineralized tissue-targeted TNAP (TNAP-Fc-D10). We hypothesized that increased TNAP would partially ameliorate developmental mineralization defects in XLH by dually reducing PPi levels and dephosphorylating and inactivating OPN. In a proof-of-principle study to investigate pathological mechanisms, we delivered systemic (subcutaneous injection) and local (submucosal injection to mandibles) TNAP-Fc-D10 injections to the Hyp mutant mouse model of XLH from 7 to 60 d postnatal (dpn). While systemic delivery was ineffective at improving dentin or bone properties, micro-CT and histology analyses demonstrated that local delivery of TNAP-Fc-D10 increased dentin thickness, root length, alveolar bone volume, alveolar bone proper (ABP) volume and density, PDL attachment, and acellular cementum thickness, compared to control Hyp mice receiving a sham injection. Dynamic mechanical testing confirmed partially improved mechanical properties in locally treated vs untreated Hyp mice, suggesting incompletely improved periodontal function. Quantitative PCR revealed increased Dspp expression in molars of treated Hyp mice. In conclusion, we found TNAP administration reduced dentoalveolar defects in Hyp mice when delivered locally into dentoalveolar structures, proof-of-principle pointing to a pathological contribution by PPi and/or OPN and highlighting a promising adjunctive approach considering limitations of current treatment modalities.
- Open Access
- 8 October 2025
- Published by Wiley in Journal of Periodontal Research
- Vol. 61 (3) , 309-322
Targeted Alkaline Phosphatase Therapy Enhances Alveolar Bone Healing in X‐Linked Hypophosphatemia in Mice
Aim: X‐linked Hypophosphatemia (XLH), caused by PHEX mutations, hinders skeletal and dental mineralization and contributes to tooth loss. While XLH is associated with dental implant‐related complications, no clinical or preclinical studies have investigated socket healing. XLH secondarily disrupts local mineral metabolism by increasing levels of the mineralization inhibitors, osteopontin (OPN) and inorganic pyrophosphate (PP i ). Tissue‐nonspecific alkaline phosphatase (TNAP) promotes mineralization by dephosphorylating OPN and hydrolyzing PP i . In this proof‐of‐principle study, we hypothesized that alveolar bone socket healing defects in the Hyp mouse model of XLH would be improved by exogenous TNAP. Methods: Maxillary first molars were extracted from wild‐type (WT) and Hyp mice at 6 weeks, and collagen gel ± mineral‐targeted TNAP (TNAP‐Fc‐D 10 ; asfotase alfa) was placed in sockets. Submucosal injections of TNAP‐Fc‐D 10 or saline were delivered at 7 and 14 days post‐procedure (dpp) in some mice. Maxillae were collected at 21 dpp for micro‐computed tomography, histology, and RT‐qPCR. Results: Untreated Hyp mice showed impaired socket healing compared to WT mice in bone volume and density. TNAP delivered at the time of extraction was unable to improve healing in Hyp mice. However, additional local TNAP delivery increased both alveolar bone volume and density in Hyp mice. Histology indicated repeated TNAP increased both woven and mature bone in Hyp mouse sockets. Immunostaining for osteopontin and bone sialoprotein suggested partial resolution of osteoid accumulation. Conclusion: TNAP enhanced socket healing in Hyp mice, overcoming inherent bone healing defects in XLH. These results provide new insights into bone healing with implications beyond alveolar bone in XLH.
- 8 October 2025
- Published by Wiley in Journal of Periodontal Research
- Vol. 61 (3) , 309-322
Open AccessTargeted Alkaline Phosphatase Therapy Enhances Alveolar Bone Healing in X‐Linked Hypophosphatemia in Mice
Aim: X‐linked Hypophosphatemia (XLH), caused by PHEX mutations, hinders skeletal and dental mineralization and contributes to tooth loss. While XLH is associated with dental implant‐related complications, no clinical or preclinical studies have investigated socket healing. XLH secondarily disrupts local mineral metabolism by increasing levels of the mineralization inhibitors, osteopontin (OPN) and inorganic pyrophosphate (PP i ). Tissue‐nonspecific alkaline phosphatase (TNAP) promotes mineralization by dephosphorylating OPN and hydrolyzing PP i . In this proof‐of‐principle study, we hypothesized that alveolar bone socket healing defects in the Hyp mouse model of XLH would be improved by exogenous TNAP. Methods: Maxillary first molars were extracted from wild‐type (WT) and Hyp mice at 6 weeks, and collagen gel ± mineral‐targeted TNAP (TNAP‐Fc‐D 10 ; asfotase alfa) was placed in sockets. Submucosal injections of TNAP‐Fc‐D 10 or saline were delivered at 7 and 14 days post‐procedure (dpp) in some mice. Maxillae were collected at 21 dpp for micro‐computed tomography, histology, and RT‐qPCR. Results: Untreated Hyp mice showed impaired socket healing compared to WT mice in bone volume and density. TNAP delivered at the time of extraction was unable to improve healing in Hyp mice. However, additional local TNAP delivery increased both alveolar bone volume and density in Hyp mice. Histology indicated repeated TNAP increased both woven and mature bone in Hyp mouse sockets. Immunostaining for osteopontin and bone sialoprotein suggested partial resolution of osteoid accumulation. Conclusion: TNAP enhanced socket healing in Hyp mice, overcoming inherent bone healing defects in XLH. These results provide new insights into bone healing with implications beyond alveolar bone in XLH.
- Open Access
- 1 October 2025
- Published by MDPI AG in Applied Sciences
- Vol. 15 (19) , 10639
In Vivo Comparison of Resin-Modified and Pure Calcium-Silicate Cements for Direct Pulp Capping
Introduction: Direct pulp capping (DPC) aims to preserve the vitality of the dental pulp by placing a protective biocompatible material over the exposed pulp tissue to facilitate healing. There are several calcium-silicate materials that have been designed to promote mineralization and the regulation of inflammation. These have strong potential for the repair and regeneration of dental pulp. Among them, Biodentine (BD) and EndoSequence RRM Putty (ES) have been found to promote in vitro and in vivo mineralization while minimizing some of the limitations of the first-generation calcium-silicate-based materials. Theracal-LC (TLC), a light-cured, resin-modified calcium-silicate material, is a newer product with potential to improve the clinical outcomes of DPC, but existing studies have reported conflicting findings regarding its biocompatibility and ability to support pulpal healing in direct contact with the pulp. A comprehensive assessment of the biocompatibility and pulpal protection provided by these three capping materials has not yet been performed. Aim: We aimed to quantify the inflammatory response, dentin bridge formation, and material adaptation following DPC using three calcium-silicate materials: ES, BD, and TLC. Materials and Methods: DPC was performed on the maxillary first molar of C57BL/6 female mice. Maxilla were collected and processed at 1 and 21 days post-DPC. The early inflammatory response was measured 24 h post-procedure using confocal imaging of anti-Lys6G6C, which indicates the extent of neutrophil and monocyte infiltration. Reparative mineralized bridge formation was assessed at 21 days post-procedure using high-resolution micro-computed tomography (micro-CT) and histology. Lastly, the homogeneity of the capping materials was evaluated by quantifying voids in calcium-silicate restorations using micro-CT. Results: DPC using TLC induced less infiltration of Lys6G6C+ cells at 24 h than BD or ES. BD promoted higher volumes of tertiary dentin than TLC, but TLC and ES showed no significant differences in volume. No differences were observed in material adaptation and void spaces among the three capping materials. Conclusions: All three materials under investigation supported pulp healing and maintained marginal integrity. However, TLC induced a lower inflammatory response on day 1 and induced similar levels of tertiary dentin to ES. These observations challenge the common perception that resin-based capping materials are not suitable for direct pulp capping. Our findings underscore the need to balance biological responses with physical properties when selecting pulp capping materials to improve long-term clinical success.
- 1 October 2025
- Published by MDPI AG in Applied Sciences
- Vol. 15 (19) , 10639
Open AccessIn Vivo Comparison of Resin-Modified and Pure Calcium-Silicate Cements for Direct Pulp Capping
Introduction: Direct pulp capping (DPC) aims to preserve the vitality of the dental pulp by placing a protective biocompatible material over the exposed pulp tissue to facilitate healing. There are several calcium-silicate materials that have been designed to promote mineralization and the regulation of inflammation. These have strong potential for the repair and regeneration of dental pulp. Among them, Biodentine (BD) and EndoSequence RRM Putty (ES) have been found to promote in vitro and in vivo mineralization while minimizing some of the limitations of the first-generation calcium-silicate-based materials. Theracal-LC (TLC), a light-cured, resin-modified calcium-silicate material, is a newer product with potential to improve the clinical outcomes of DPC, but existing studies have reported conflicting findings regarding its biocompatibility and ability to support pulpal healing in direct contact with the pulp. A comprehensive assessment of the biocompatibility and pulpal protection provided by these three capping materials has not yet been performed. Aim: We aimed to quantify the inflammatory response, dentin bridge formation, and material adaptation following DPC using three calcium-silicate materials: ES, BD, and TLC. Materials and Methods: DPC was performed on the maxillary first molar of C57BL/6 female mice. Maxilla were collected and processed at 1 and 21 days post-DPC. The early inflammatory response was measured 24 h post-procedure using confocal imaging of anti-Lys6G6C, which indicates the extent of neutrophil and monocyte infiltration. Reparative mineralized bridge formation was assessed at 21 days post-procedure using high-resolution micro-computed tomography (micro-CT) and histology. Lastly, the homogeneity of the capping materials was evaluated by quantifying voids in calcium-silicate restorations using micro-CT. Results: DPC using TLC induced less infiltration of Lys6G6C+ cells at 24 h than BD or ES. BD promoted higher volumes of tertiary dentin than TLC, but TLC and ES showed no significant differences in volume. No differences were observed in material adaptation and void spaces among the three capping materials. Conclusions: All three materials under investigation supported pulp healing and maintained marginal integrity. However, TLC induced a lower inflammatory response on day 1 and induced similar levels of tertiary dentin to ES. These observations challenge the common perception that resin-based capping materials are not suitable for direct pulp capping. Our findings underscore the need to balance biological responses with physical properties when selecting pulp capping materials to improve long-term clinical success.
- Open Access
Comparative Evaluation of Three Calcium Silicate-Based Materials for Direct Pulp Capping: An In Vivo Study in Mice
Introduction Vital pulp treatments (VPT) aim to conservatively manage deep caries and/or damage to preserve the vitality and function of the pulp. This minimally invasive approach is still debated when performing direct pulp capping (DPC), a treatment in which a protective biocompatible material is directly placed over the dental pulp, due to microbial risks inherent with pulp exposure and difficulties in sealing the exposure to protect the pulp from subsequent bacterial ingress. Several limitations associated with Mineral Trioxide Aggregate (MTA) such as long setting time and discoloration have promoted the development of next-generation MTA derivatives with enhanced physical, chemical, and biological properties. As these materials are relatively new, existing studies are limited in scope, lacking a comprehensive assessment of both reparative dentin formation and the sealing ability, which are critical parameters for determining long-term clinical success. These assessments require preclinical models, and while the mouse model offers the opportunity to explore the molecular mechanisms guiding reparative dentinogenesis, the materials and techniques optimized for human dentition present technical challenges in mice due to their small size. Aim We aimed to optimize a DPC technique to use in mice by comparing the tissue responses and the sealing ability of three calcium silicate capping agents: Bioceramic putty (BC), Biodentine (BD), and Theracal-LC (TLC) to a control material known to seal well but cause desiccation that would lead to tissue damage; Cavit-G (CG). Material and methods DPC was performed on the maxillary first molar of C57BL/6 female mice. Reparative dentin was assessed with micro-computed tomography (micro-CT) and histological assessment of dentin bridge formation at 21 days. The sealing ability of the capping materials was evaluated using micro-CT. Results All three calcium silicate materials showed good biocompatibility and the ability to form a dentin bridge. Micro-CT quantifications of material voids demonstrated superior seals with bioceramic putty and Theracal-LC groups as compared to Biodentine. Conclusions Ready-to-use, premixed capping agents exhibit better sealing ability in mice, while promoting dentin bridge formation to protect the dental pulp.
Open AccessComparative Evaluation of Three Calcium Silicate-Based Materials for Direct Pulp Capping: An In Vivo Study in Mice
Introduction Vital pulp treatments (VPT) aim to conservatively manage deep caries and/or damage to preserve the vitality and function of the pulp. This minimally invasive approach is still debated when performing direct pulp capping (DPC), a treatment in which a protective biocompatible material is directly placed over the dental pulp, due to microbial risks inherent with pulp exposure and difficulties in sealing the exposure to protect the pulp from subsequent bacterial ingress. Several limitations associated with Mineral Trioxide Aggregate (MTA) such as long setting time and discoloration have promoted the development of next-generation MTA derivatives with enhanced physical, chemical, and biological properties. As these materials are relatively new, existing studies are limited in scope, lacking a comprehensive assessment of both reparative dentin formation and the sealing ability, which are critical parameters for determining long-term clinical success. These assessments require preclinical models, and while the mouse model offers the opportunity to explore the molecular mechanisms guiding reparative dentinogenesis, the materials and techniques optimized for human dentition present technical challenges in mice due to their small size. Aim We aimed to optimize a DPC technique to use in mice by comparing the tissue responses and the sealing ability of three calcium silicate capping agents: Bioceramic putty (BC), Biodentine (BD), and Theracal-LC (TLC) to a control material known to seal well but cause desiccation that would lead to tissue damage; Cavit-G (CG). Material and methods DPC was performed on the maxillary first molar of C57BL/6 female mice. Reparative dentin was assessed with micro-computed tomography (micro-CT) and histological assessment of dentin bridge formation at 21 days. The sealing ability of the capping materials was evaluated using micro-CT. Results All three calcium silicate materials showed good biocompatibility and the ability to form a dentin bridge. Micro-CT quantifications of material voids demonstrated superior seals with bioceramic putty and Theracal-LC groups as compared to Biodentine. Conclusions Ready-to-use, premixed capping agents exhibit better sealing ability in mice, while promoting dentin bridge formation to protect the dental pulp.
- Open Access
- 16 July 2024
- Published by Wiley in Journal of Periodontology
- Vol. 96 (1) , 82-96
Disparate effects of sclerostin deletion on alveolar bone and cellular cementum in mice
Background: Cellular cementum (CC) includes cementocytes, cells suspected to regulate CC formation or resorption as osteocytes do in bone. Sclerostin (SOST) is a secreted negative regulator of Wnt/β‐catenin signaling expressed by osteocytes and cementocytes. Osteocyte SOST expression reduces bone formation. We investigated the functional importance of SOST in CC compared with alveolar bone (AB) using a Sost knockout (Sost−/−) mouse model to better understand the role of cementocytes in CC.Methods: Mandibles and femurs of Sost−/− and wild‐type (WT) mice were analyzed at 42 and 120 days postnatal (dpn). Maxillary first molars were bilaterally extracted at 42 dpn and both AB healing (maxillary molar sockets) and CC apposition (mandibular first molars) were examined at 21 days post‐procedure. Analyses included micro‐computed tomography, histology, and immunohistochemistry.Results: Femur cortical and trabecular bone and mandibular bone volumes were similarly increased in Sost−/− versus WT mice at 42 and/or 120 dpn. In contrast to previous reports, CC was not increased by Sost−/− at either age. We conducted challenge experiments on AB and CC to explore tissue‐specific responses. Post‐extraction AB healing was improved by Sost deletion. In contrast, experimentally‐induced apposition in molars failed to stimulate increased CC formation in Sost−/− versus WT mice. Wnt pathway markers AXIN2 and DKK1, which were increased in Sost−/− versus WT AB osteocytes, were unchanged in cementocytes.Conclusions: These data indicate CC is less responsive than AB to SOST deletion. Within the study limitations, these results do not support cementocytes as critical for directing increased CC formation.Plain Language Summary: Sclerostin is a protein known to inhibit bone formation, and removing sclerostin leads to more bone formation. Cementum is the thin layer that covers the surface of the tooth's root. Previous studies suggest that inhibiting sclerostin can similarly increase the amount of cementum. We wanted to compare the response of cementum and bone when sclerostin is absent to understand similarities and differences between these two tissues. In this study, we removed the Sost gene (the gene which produces sclerostin) in mice. We found that mice without sclerostin have more bone in their legs and jaws. Moreover, mice without sclerostin also healed better after tooth removal compared with normal mice. Surprisingly, unlike previous studies, we found that the amount of cementum was not different in mice without sclerostin compared with normal mice. Additionally, we challenged the cementum by taking out the opposing tooth to cause the first mandibular molar to move up by building more cementum. Even with this challenge, we found no difference in the amount of cementum in mice lacking sclerostin compared with normal mice. Therefore, we conclude here that cementum is less sensitive to the absence of sclerostin compared with bone.
- 16 July 2024
- Published by Wiley in Journal of Periodontology
- Vol. 96 (1) , 82-96
Open AccessDisparate effects of sclerostin deletion on alveolar bone and cellular cementum in mice
Background: Cellular cementum (CC) includes cementocytes, cells suspected to regulate CC formation or resorption as osteocytes do in bone. Sclerostin (SOST) is a secreted negative regulator of Wnt/β‐catenin signaling expressed by osteocytes and cementocytes. Osteocyte SOST expression reduces bone formation. We investigated the functional importance of SOST in CC compared with alveolar bone (AB) using a Sost knockout (Sost−/−) mouse model to better understand the role of cementocytes in CC.Methods: Mandibles and femurs of Sost−/− and wild‐type (WT) mice were analyzed at 42 and 120 days postnatal (dpn). Maxillary first molars were bilaterally extracted at 42 dpn and both AB healing (maxillary molar sockets) and CC apposition (mandibular first molars) were examined at 21 days post‐procedure. Analyses included micro‐computed tomography, histology, and immunohistochemistry.Results: Femur cortical and trabecular bone and mandibular bone volumes were similarly increased in Sost−/− versus WT mice at 42 and/or 120 dpn. In contrast to previous reports, CC was not increased by Sost−/− at either age. We conducted challenge experiments on AB and CC to explore tissue‐specific responses. Post‐extraction AB healing was improved by Sost deletion. In contrast, experimentally‐induced apposition in molars failed to stimulate increased CC formation in Sost−/− versus WT mice. Wnt pathway markers AXIN2 and DKK1, which were increased in Sost−/− versus WT AB osteocytes, were unchanged in cementocytes.Conclusions: These data indicate CC is less responsive than AB to SOST deletion. Within the study limitations, these results do not support cementocytes as critical for directing increased CC formation.Plain Language Summary: Sclerostin is a protein known to inhibit bone formation, and removing sclerostin leads to more bone formation. Cementum is the thin layer that covers the surface of the tooth's root. Previous studies suggest that inhibiting sclerostin can similarly increase the amount of cementum. We wanted to compare the response of cementum and bone when sclerostin is absent to understand similarities and differences between these two tissues. In this study, we removed the Sost gene (the gene which produces sclerostin) in mice. We found that mice without sclerostin have more bone in their legs and jaws. Moreover, mice without sclerostin also healed better after tooth removal compared with normal mice. Surprisingly, unlike previous studies, we found that the amount of cementum was not different in mice without sclerostin compared with normal mice. Additionally, we challenged the cementum by taking out the opposing tooth to cause the first mandibular molar to move up by building more cementum. Even with this challenge, we found no difference in the amount of cementum in mice lacking sclerostin compared with normal mice. Therefore, we conclude here that cementum is less sensitive to the absence of sclerostin compared with bone.